X0306 4 2020-07-01 0 0001623526 Stoke Therapeutics, Inc. STOK 0001780085 Nash Huw M. C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE BEDFORD MA 01730 0 1 0 0 COO & CBO Common Stock 2020-07-01 4 M 0 3800 2.19 A 3800 D Common Stock 2020-07-01 4 S 0 3800 23.1494 D 0 D Employee Stock Option (Right to Buy) 2.19 2020-07-01 4 M 0 3800 0.00 D 2018-12-12 Common Stock 3800 224911 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.88 to $23.80 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vests 1/48th of the shares monthly,commencing one month from the date of grant, subject to reporting person's continued service through each vesting date. /s/ Stephen Tulipano, Attorney-in-Fact 2020-07-02